Manuel Abecasis

2.1k citations
24 papers · 865 indexed · h-index 11

Manuel Abecasis

23 papers receiving 854 citations

Peers

Manuel Abecasis
Comparison fields: 5 of 73
  • Hematology 488
  • Transplantation 59
  • Infectious Diseases 180
  • Immunology 198
  • Genetics 86
Replace Mats Remberger with:
Mats Remberger Sweden
Elisabetta Calore Italy
Claude‐Eric Bulabois France
Javier Anguita Spain
Joerg Halter Switzerland
Diane George United States
EP Smith United States
Roni Tamari United States
David Michonneau France
Ken Ishiyama Japan
Manuel Abecasis relative to Mats Remberger Sweden Mats Remberger's profile →
Citations per field
00.5×1.5×
Mats Remberger · 1×
Citations per year

Countries citing papers authored by Manuel Abecasis

Since Specialization
Citations

This map shows the geographic impact of Manuel Abecasis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Manuel Abecasis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Manuel Abecasis more than expected).

Fields of papers citing papers by Manuel Abecasis

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Manuel Abecasis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Manuel Abecasis. The network helps show where Manuel Abecasis may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Manuel Abecasis, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Manuel Abecasis Line = papers co-authored together Manuel Abecasis links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 20223
2 202013
3 20201
4 201623
5 20164
6 20161
7 20133
8 20137
9 20133
10 201183
11 20110
12 201093
13 201041
14 201038
15 200611
16 200221
17 19982
18 1997473
19 19955
20
High-dose melphalan with autologous bone marrow rescue for the treatment of advanced adult solid tumors.
198412

About Manuel Abecasis

Manuel Abecasis is a scholar working on Hematology, Genetics and Transplantation, having authored 24 papers that have together received 865 indexed citations. Recurring topics across this work include Hematopoietic Stem Cell Transplantation (6 papers), Chronic Lymphocytic Leukemia Research (5 papers), Chronic Myeloid Leukemia Treatments (5 papers), Antifungal resistance and susceptibility (4 papers), Acute Lymphoblastic Leukemia research (4 papers), Fungal Infections and Studies (4 papers), Acute Myeloid Leukemia Research (2 papers) and Polyomavirus and related diseases (2 papers). The work is most often cited by research in Hematology (488 citations), Transplantation (59 citations) and Infectious Diseases (180 citations). Manuel Abecasis has collaborated with scholars based in Portugal, France and Switzerland. Frequent co-authors include Jean‐Yves Cahn, Jakob Passweg, Robert Peter Gale, Mei‐Jie Zhang, Mary M. Horowitz, Stan Calderwood, P. Jean Henslee‐Downey, John P. Klein, Philip A. Rowlings and Kathleen A. Sobocinski. Their work appears in journals such as Haematologica, British Journal of Haematology, Bone Marrow Transplantation, Blood and Medicine.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026